In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a N-4-tert-butylbenzyl-N-methyl-1-naphthalene methylamine hydrochloride Drug Master File in Korea (N-4-tert-butylbenzyl-N-methyl-1-naphthalene methylamine hydrochloride KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of N-4-tert-butylbenzyl-N-methyl-1-naphthalene methylamine hydrochloride. The MFDS reviews the N-4-tert-butylbenzyl-N-methyl-1-naphthalene methylamine hydrochloride KDMF as part of the drug registration process and uses the information provided in the N-4-tert-butylbenzyl-N-methyl-1-naphthalene methylamine hydrochloride KDMF to evaluate the safety and efficacy of the drug.
After submitting a N-4-tert-butylbenzyl-N-methyl-1-naphthalene methylamine hydrochloride KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their N-4-tert-butylbenzyl-N-methyl-1-naphthalene methylamine hydrochloride API can apply through the Korea Drug Master File (KDMF).
click here to find a list of N-4-tert-butylbenzyl-N-methyl-1-naphthalene methylamine hydrochloride suppliers with KDMF on PharmaCompass.